Hydroxyurea maintains working memory function in pediatric sickle cell disease
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0296196 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jesyin Lai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Memory, Short-Term, Magnetic Resonance Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Sickle cell disease (SCD) decreases the oxygen-carrying capacity of red blood cells. Children with SCD have reduced/restricted cerebral blood flow, resulting in neurocognitive deficits. Hydroxyurea is the standard treatment for SCD; however, whether hydroxyurea influences such effects is unclear. A key area of SCD-associated neurocognitive impairment is working memory, which is implicated in other cognitive and academic skills. The neural correlates of working memory can be tested using n-back tasks. We analyzed functional magnetic resonance imaging (fMRI) data of patients with SCD (20 hydroxyurea-treated patients and 11 controls, aged 7–18 years) while they performed n-back tasks. Blood-oxygenation level–dependent (BOLD) signals were assessed during working memory processing at 2 time points: before hydroxyurea treatment and ~1 year after treatment was initiated. Neurocognitive measures were also assessed at both time points. Our results suggested that working memory was stable in the treated group. We observed a treatment-by-time interaction in the right cuneus and angular gyrus for the 2- >0-back contrast. Searchlight-pattern classification of the 2 time points of the 2-back tasks identified greater changes in the pattern and magnitude of BOLD signals, especially in the posterior regions of the brain, in the control group than in the treated group. In the control group at 1-year follow-up, 2-back BOLD signals increased across time points in several clusters (e.g., right inferior temporal lobe, right angular gyrus). We hypothesize that these changes resulted from increased cognitive effort during working memory processing in the absence of hydroxyurea. In the treated group, 0- to 2-back BOLD signals in the right angular gyrus and left cuneus increased continuously with increasing working memory load, potentially related to a broader dynamic range in response to task difficulty and cognitive effort. These findings suggest that hydroxyurea treatment helps maintain working memory function in SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
- Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
- Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
- Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
ORCID-Profile: Jesyin Lai, Akshay Sharma
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NCRR NIH HHS
- National Cancer Center
- National Center for Research Resources
- National Heart, Lung, and Blood Institute
- American Lebanese Syrian Associated Charities
Zitieren
APA
Lai, J., Zou, P., Dalboni da Rocha, J. L., Heitzer, A. M., Patni, T., Li, Y., Scoggins, M. A., Sharma, A., Wang, W. C., Helton, K. J., & Sitaram, R. (2024). Hydroxyurea maintains working memory function in pediatric sickle cell disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0296196
Vancouver
Lai J, Zou P, Dalboni da Rocha JL, Heitzer AM, Patni T, Li Y, et al. Hydroxyurea maintains working memory function in pediatric sickle cell disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0296196
BibTeX
@article{Lai2024,
author = {Lai, Jesyin and Zou, Ping and Dalboni da Rocha, Josue L and Heitzer, Andrew M and Patni, Tushar and Li, Yimei and Scoggins, Matthew A and Sharma, Akshay and Wang, Winfred C and Helton, Kathleen J and Sitaram, Ranganatha},
title = {Hydroxyurea maintains working memory function in pediatric sickle cell disease},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0296196}
}
EUVIMED